Yıl: 2021 Cilt: 36 Sayı: 2 Sayfa Aralığı: 98 - 105 Metin Dili: İngilizce DOI: 10.5222/MMJ.2021.32549 İndeks Tarihi: 02-02-2022

Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions

Öz:
Objective: Spontaneous abortion is the most common complication of early pregnancy, affecting up to 20% of recognized pregnancies. Kisspeptin is predominantly released by placental syncytiotrophoblasts, and regulates their placental invasion into the uterine matrices. We aimed to establish an association of serum kisspeptin levels with pregnancy outcomes during the early gestational stage of the first trimester. Method: In this prospective study, 90 pregnant women in their 7 to 8 6/7 gestational weeks were classified into three groups: (i) The control group, consisting of healthy pregnant women (n=30), (ii) the threatened abortion group (n=30), and (iii) the spontaneous abortion group (n=30). The maternal serum samples were analyzed for complete blood count parameters and kisspeptin levels. Results: There was no statistical difference regarding body mass index (BMI) and gestational age (p=0.370). Regarding detailed obstetric notations, including gravida, parity, abortion, and living children, socioeconomic levels, and employment rates, all study groups were comparable (p>0.05, for all). No significant association was found regarding the biochemical parameters of complete blood count, including neutrophil, lymphocyte, and platelet concentrations, as well as neutrophil-to-lymphocyte ratios (NLR) and platelet-to-lymphocyte ratios (PLR) (p>0.05, for all). The median serum kisspeptin levels of the study groups did not differ between the groups (p=0.153). Correlation analysis revealed no significant relationship between serum kisspeptin levels and other study parameters in any study groups (p>0.05, for all) Conclusions: We found no statistically significant relationship between serum kisspeptin concentrations and pregnancy outcomes in the early gestational stage of the first trimester, and serum kisspeptin concentrations did not seem to be a reliable marker to distinguish abortion status from viable pregnancy.
Anahtar Kelime:

İlk Trimester Düşükleri İçin Öngörücü Biyobelirteçler Olarak Kisspeptin ve Hematolojik Parametreler

Öz:
Amaç: Spontan abortus, erken gebeliğin en sık görülen komplikasyonudur ve tanınan gebeliklerin % 20’sini etkilemektedir. Kisspeptin, plasental sinsitiyotrofoblastlar tarafından salınmakta olup rahim matrislerine plasental invazyonu düzenlemektedir. Biz bu çalışmada ilk trimesterin erken gebelik evresindeki gebelik sonuçları ile serum kisspeptin düzeyleri arasında bir ilişki kurmayı amaçladık. Yöntem: Bu prospektif çalışmada, 7-8 6/7 hafta gebelikleri olan doksan gebe toplam üç gruba ayrıldı: (i) sağlıklı gebelerden oluşan kontrol grubu (n=30), (ii) düşük tehdidi grubu (n=30) ve (iii) spontan düşük grubu (n=30). Maternal serum örnekleri, tam kan sayımı parametreleri ve kisspeptin seviyeleri analiz edildi. Bulgular: Vücut kütle indeksi ve gebelik yaşı açısından istatistiksel olarak fark yoktu (p=0.370). Gravida, parite, kürtaj ve yaşayan çocuklar, sosyo-ekonomik düzey ve istihdam dahil olmak üzere ayrıntılı obstetrik durumlarla ilgili olarak çalışma grupları arasında fark yoktu (p>0.05). Nötrofil, lenfosit ve trombosit sayılarının yanı sıra nötrofil-lenfosit oranı (NLR) ve trombosit-lenfosit oranı (PLR) dahil olmak üzere tam kan sayımının biyokimyasal parametreleri açısından önemli bir ilişki bulunmadı (p>0.05). Çalışma grupları arasında medyan serum kisspeptin seviyeleri anlamlı farklılık göstermedi (p=0.153). Korelasyon analiz testi tüm çalışma gruplarında kisspeptin ile diğer çalışma parametreleri arasında bir korelasyonun olmadığını gösterdi (p>0.05). Sonuç: Bulgularımız, birinci trimesterin erken gebelik evresinde serum kisspeptin konsantrasyonu ile gebelik sonuçları arasında herhangi bir ilişkinin olmadığını ve serum kisspeptin konsantrasyo- nunun düşük durumunu canlı gebeliklerden ayırt etmek için güvenilir bir belirteç olmadığını göstermiştir.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Kotani M, Detheux M, Vandenbogaerde A, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein coupled receptor GPR54. J Biol Chem. 2001;276:34631-6. [CrossRef]
  • 2. Reynolds RM, Logie JJ, Roseweir AK, McKnight AJ, Millar RP. A role for kisspeptins in pregnancy: facts and speculations. Reproduction. 2009;138:1-7. [CrossRef]
  • 3. Gorkem U, Togrul C, Arslan E, Sargin Oruc A, Buyukkayaci Duman N. Is there a role for kisspeptin in pathogenesis of polycystic ovary syndrome? Gynecol Endocrinol. 2018;34:157-60. [CrossRef]
  • 4. Comninos AN, Anastasovska J, Sahuri-Arisoylu M, et al. Kisspeptin signaling in the amygdala modulates reproductive hormone secretion. Brain Struct Funct. 2016;221:2035-47. [CrossRef]
  • 5. Uenoyama Y, Pheng V, Tsukamura H, Maeda KI. The roles of kisspeptin revisited: inside and outside the hypothalamus. J Reprod Dev. 2016;62:537-45. [CrossRef]
  • 6. Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G protein- coupled receptor. Nature. 2001;411:613-7. [CrossRef]
  • 7. Mead EJ, Maguire JJ, Kuc RE, Davenport AP. Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localisation of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. Endocrinology. 2007;148:140-7. [CrossRef]
  • 8. Matjila M, Millar R, van der Spuy Z, Katz A. The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development. PLoS One. 2013;8:e63574. [CrossRef]
  • 9. Horikoshi Y, Matsumoto H, Takatsu Y, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88:914-9. [CrossRef]
  • 10. Bilban M, Ghaffari-Tabrizi N, Hintermann E, et al. Kisspeptin-10, a KiSS-1/metastin derived decapeptide is a physiological invasion inhibitor of primary human trophoblast. J Cell Sci. 2004;117:1319-28. [CrossRef]
  • 11. Basini G, Grasselli F, Bussolati S, et al. Presence and function of kisspeptin/KISS1R system in swine ovarian follicles. Theriogenology. 2018;115:1-8. [CrossRef]
  • 12. Shahed A, Young KA. Differential ovarian expression of KiSS-1 and GPR-54 during the estrous cycle and photoperiod induced recrudescence in Siberian hamsters (Phodopus sungorus). Mol Reprod Dev. 2009;76:444- 52. [CrossRef]
  • 13. Babwah AV. Uterine and placental KISS1 regulate pregnancy: what we know and the challenges that lie ahead. Reproduction. 2015;150:R121-8. [CrossRef]
  • 14. Inal ZO, Inal HA. Comparison of four methods of treating ectopic pregnancy: a retrospective cohort study. Geburtshilfe Frauenheilde. 2018;78:70-7. [CrossRef]
  • 15. Ozturk Inal Z, Gorkem U, Inal HA. Effects of preoperative anxiety on postcesarean delivery pain and analgesic consumption: general versus spinal anesthesia. J Matern Fetal Neonatal Med. 2020;33:191-7. [CrossRef]
  • 16. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ. 1997;315:32-4. [CrossRef]
  • 17. Inal ZO, Inal HA, Kucukkendirci H, Oruc AS. Investigation of cesarean sections at Konya Training and Research Hospital Obstetrics and Gynecology Department between 2010 and 2015. Ginekol Pol. 2017;88:185-90. [CrossRef]
  • 18. Gorkem U, Inal ZO, Inal HA, Bostanci MO. Serum progranulin levels are elevated in infertile women with obesity. Endokrynol Pol. 2018;69:661-6. [CrossRef]
  • 19. Çakıroğlu Y, Vural F, Vural B. The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J Endocrinol Invest. 2016;39:899-907. [CrossRef]
  • 20. Doubilet PM, Benson CB, Bourne T, Blaivas M. Diagnostic criteria for nonviable pregnancy early in the first trimester. N Engl J Med. 2013;369:1443-51. [CrossRef]
  • 21. DSS Research. Researcher’s toolkit. Available at: http:// www.dssresearch.com/toolkit/sscalc.
  • 22. Cartwright JE, Williams PJ. Altered placental expression of kisspeptin and its receptor in pre-eclampsia. J Endocrinol. 2012;214:79-85. [CrossRef]
  • 23. Kavvasoglu S, Ozkan ZS, Kumbak B, Simsek M, Ilhan N. Association of kisspeptin-10 levels with abortus imminens: a preliminary study. Arch Gynecol Obstet. 2012;285:649-53. [CrossRef]
  • 24. Hu KL, Zhao H, Yu Y, Li R. Kisspeptin as a potential biomarker throughout pregnancy. Eur J Obstet Gynecol Reprod Biol. 2019;240:261-6. [CrossRef]
  • 25. Wolfe A, Hussain MA. The emerging role(s) for kisspeptin in metabolism in mammals. Front Endocrinol (Lausanne). 2018;24:184. [CrossRef]
  • 26. Dudek M, Ziarniak K, Sliwowska JH. Kisspeptin and metabolism: the brain and beyond. Front Endocrinol (Lausanne). 2018;9:145. [CrossRef]
  • 27. Armstrong RA, Reynolds RM, Leask R, Shearing CH, Calder AA, Riley SC. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia. Prenat Diagn. 2009;29:982-5. [CrossRef]
  • 28. Cetkovic A, Miljic D, Ljubic A, et al. Plasma kisspeptin levels in pregnancies with diabetes and hypertensive disease as a potential marker of placental dysfunction and adverse perinatal outcome. Endocr Res. 2012;37:78-88. [CrossRef]
  • 29. Arslan E, Gorkem U, Togrul C. Is there an association between kisspeptin levels and gestational diabetes mellitus? Gynecol Obstet Reprod Med. 2019;26:179-83. [CrossRef]
  • 30. Smets EM, Deurloo KL, Go AT, van Vugt JM, Blankenstein MA, Oudejans CB. Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates. Prenat Diagn. 2008;28:299-303. [CrossRef]
  • 31. Savaris RF. Kisspeptin as a biomarker for miscarriage: let’s wait! Fertil Steril. 2018;109:67. [CrossRef]
  • 32. Jayasena CN, Abbara A, Izzi-Engbeaya C, et al. Reduced levels of plasma kisspeptin during the antenatal booking visit are associated with increased risk of miscarriage. J Clin Endocrinol Metab. 2014;99:E2652-60. [CrossRef]
  • 33. Sullivan-Pyke C, Haisenleder DJ, Senapati S, et al. Kisspeptin as a new serum biomarker to discriminate miscarriage from viable intrauterine pregnancy. Fertil Steril. 2018;109:137-141.e2. [CrossRef]
  • 34. Biyik I, Albayrak M, Keskin F. Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in missed abortion. Rev Bras Ginecol Obstet. 2020;42:235-9. [CrossRef]
  • 35. Ata N, Kulhan M, Kulhan NG, Turkler C. Can neutrophil- lymphocyte and platelet-lymphocyte ratios predict threatened abortion and early pregnancy loss? Ginekol Pol. 2020;91:210-5. [CrossRef]
  • 36. Yildirim FB, Tola EN, Sak S, Cankaya BA. The role of complete blood inflammation markers in the prediction of spontaneous abortion. Pak J Med Sci. 2018;34:1381-5. [CrossRef]
  • 37. Yu H, Liu J, Guo H, Chen C, Han Y, Cui Y. Prognostic value of repeated serum kisspeptin measurements in early first trimester pregnancy: a preliminary study. Reprod Biomed Online. 2019;38:465-71. [CrossRef]
  • 38. Hu KL, Zhang Y, Yang Z, et al. Predictive value of serum kisspeptin concentration at 14 and 21 days after frozen-thawed embryo transfer. Reprod Biomed Online. 2019;39:161-7. [CrossRef]
  • 39. Yan C, Wang H, Boyd DD. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of kappa alpha- induced block of p65/p50 nuclear translocation. J Biol Chem. 2001;276:1164-72. [CrossRef]
  • 40. Hussain MA, Song WJ, Wolfe A. There is kisspeptin- and then there is kisspeptin. Trends Endocrinol Metab. 2015;26: 564-72. [CrossRef]
  • 41. Song WJ, Mondal P, Wolfe A, et al. Glucagon regulates hepatic kisspeptin to impair insulin secretion. Cell Metab. 2014;19:667-81. [CrossRef]
  • 42. d’Anglemont de Tassigny X, Jayasena C, Murphy KG, Dhillo WS, Colledge WH. Mechanistic insights into the more potent effect of KP-54 compared to KP-10 in vivo. PLoS One. 2017;12:e0176821. Erratum in: PLoS One. 2018;13:e0192014. [CrossRef]
APA GORKEM U, kan o, BOSTANCI M, Taşkıran D, Inal H (2021). Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. , 98 - 105. 10.5222/MMJ.2021.32549
Chicago GORKEM Umit,kan ozgur,BOSTANCI Mehmet Ömer,Taşkıran Deniz,Inal Hasan Ali Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. (2021): 98 - 105. 10.5222/MMJ.2021.32549
MLA GORKEM Umit,kan ozgur,BOSTANCI Mehmet Ömer,Taşkıran Deniz,Inal Hasan Ali Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. , 2021, ss.98 - 105. 10.5222/MMJ.2021.32549
AMA GORKEM U,kan o,BOSTANCI M,Taşkıran D,Inal H Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. . 2021; 98 - 105. 10.5222/MMJ.2021.32549
Vancouver GORKEM U,kan o,BOSTANCI M,Taşkıran D,Inal H Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. . 2021; 98 - 105. 10.5222/MMJ.2021.32549
IEEE GORKEM U,kan o,BOSTANCI M,Taşkıran D,Inal H "Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions." , ss.98 - 105, 2021. 10.5222/MMJ.2021.32549
ISNAD GORKEM, Umit vd. "Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions". (2021), 98-105. https://doi.org/10.5222/MMJ.2021.32549
APA GORKEM U, kan o, BOSTANCI M, Taşkıran D, Inal H (2021). Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. Medeniyet Medical Journal, 36(2), 98 - 105. 10.5222/MMJ.2021.32549
Chicago GORKEM Umit,kan ozgur,BOSTANCI Mehmet Ömer,Taşkıran Deniz,Inal Hasan Ali Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. Medeniyet Medical Journal 36, no.2 (2021): 98 - 105. 10.5222/MMJ.2021.32549
MLA GORKEM Umit,kan ozgur,BOSTANCI Mehmet Ömer,Taşkıran Deniz,Inal Hasan Ali Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. Medeniyet Medical Journal, vol.36, no.2, 2021, ss.98 - 105. 10.5222/MMJ.2021.32549
AMA GORKEM U,kan o,BOSTANCI M,Taşkıran D,Inal H Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. Medeniyet Medical Journal. 2021; 36(2): 98 - 105. 10.5222/MMJ.2021.32549
Vancouver GORKEM U,kan o,BOSTANCI M,Taşkıran D,Inal H Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions. Medeniyet Medical Journal. 2021; 36(2): 98 - 105. 10.5222/MMJ.2021.32549
IEEE GORKEM U,kan o,BOSTANCI M,Taşkıran D,Inal H "Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions." Medeniyet Medical Journal, 36, ss.98 - 105, 2021. 10.5222/MMJ.2021.32549
ISNAD GORKEM, Umit vd. "Kisspeptin and Hematologic Parameters as Predictive Biomarkers for First-Trimester Abortions". Medeniyet Medical Journal 36/2 (2021), 98-105. https://doi.org/10.5222/MMJ.2021.32549